Trial Profile
Clinical Trials Insight: 700028827
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Nov 2007
Price :
$35
*
At a glance
- Drugs Iclaprim (Primary)
- Indications Chlamydial infections; Gonorrhoea; Nosocomial infections; Nosocomial pneumonia; Skin and soft tissue infections
- Focus Pharmacokinetics
- Sponsors Arpida
- 27 Nov 2007 New trial record.